Fine Foods & Pharmaceuticals N T M S p A : TREASURY SHARES BUYBACK INFORMATION - 17 JANUARY – 21 JANUARY 2022 PERIOD
January 24, 2022 at 05:54 am EST
Share
TREASURY SHARES BUYBACK INFORMATION
17 JANUARY - 21 JANUARY 2022 PERIOD
Verdellino (BG), 24 January 2022
Fine Foods & Pharmaceuticals N.T.M. S.p.A. as part of its treasury share buyback programme (the Programme) - which was announced to the market on 21 April 2021 and launched on 21 April 2021 implementing the 21 April 2021 Shareholders' Meeting resolution - in the 17 JANUARY - 21 JANUARY 2022 period, purchased 400 treasury shares, (equal to 0.0016% of the share capital), at an average weighted price of € 13.7250, for a total value of € 5,490.00.
The buyback was made through the intermediary Banca Akros, LEI Code 549300GRXFI7D6PNEA68.
Below are the daily details of the buyback of Fine Foods & Pharmaceuticals N.T.M. S.p.A. ordinary shares, ISIN code IT0005215329, and the attached details of the transactions carried out during the above period
Date
Market
Purchase-
No. of
Qty
Currency
Price
Total
Name
Sale
Transactions
18/01/2022
MTA
P
1
200
EUR
13.8500
2,770.00
19/01/2022
MTA
P
1
100
EUR
13.6000
1,360.00
21/01/2022
MTA
P
1
100
EUR
13.6000
1,360.00
Following the buyback outlined in this press release, the Company 1,306,331 treasury shares, representing 5.1108% of the share capital, as of 21 January 2022.
more detail below
***
This press release is available on the Fine Foods website www.finefoods.it,in the Investor Relations/Press Releases section.
4 / 6
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Via Berlino, 39 Zingonia-Verdellino 24040 (BG) Italia
CF / P.IVA IT 09320600969
T. +39 035 4821382 info@finefoods.it
CAP. SOC. € 22.770.445,02
***
Fine Foods & Pharmaceuticals N.T.M. S.p.A., listed on Euronext STAR Milan, is an Italian independent Contract Development & Manufacturing Organisation (CDMO). It develops and manufactures contract products for the pharmaceutical and nutraceutical industries. Fine Foods is also active in the cosmetics, biocides and medical devices industries with its acquisition of Pharmatek-PMC and the most recent Euro Cosmetic acquisition.
Founded in 1984, from a pharmaceutical and nutraceutical synergy, Fine Foods has been pursuing quality and innovation on behalf of its customers as its primary objective. With € 172 million revenue in 2020 and an 11 per cent CAGR over the last decade, it is a growing and future-oriented company.
The sustainability of the business model and the holistic approach to ESG, together with product innovation, are drivers that will allow the company to fully develop its intrinsic potential.
***
For information:
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
CDR Communication
Investor Relations
Media Relations
tel. +39 035 4821382
Marianna Tremolada
ir@finefoods.it
marianna.tremolada@cdr-communication.it
5 / 6
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Via Berlino, 39 Zingonia-Verdellino 24040 (BG) Italia
CF / P.IVA IT 09320600969
T. +39 035 4821382 info@finefoods.it
CAP. SOC. € 22.770.445,02
ATTACHMENT
Date
Market
Purchase-
Trade
Q.ty
Value
Price
Total
Sell
Time
18/01/2022
MTAA
P
17:28:22
200
EUR
13,85
2770
19/01/2022
MTAA
P
11:14:44
100
EUR
13,6
1360
21/01/2022
MTAA
P
13:04:28
100
EUR
13,6
1360
6 / 6
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Via Berlino, 39 Zingonia-Verdellino 24040 (BG) Italia
CF / P.IVA IT 09320600969
T. +39 035 4821382 info@finefoods.it
CAP. SOC. € 22.770.445,02
Attachments
Original Link
Original Document
Permalink
Disclaimer
Fine Foods & Pharmaceuticals NTM S.p.A. published this content on 24 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 January 2022 10:53:06 UTC.
Fine Foods & Pharmaceuticals NTM SpA, formerly Innova Italy 1 SpA, is an Italy-based pharmaceutical company. It is specialized in the manufacturing of pharmaceutical products for third parties. The Company manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.
FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A. 
